Insider Trading activities of Adaptimmune Therapeutics Plc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adaptimmune Therapeutics Plc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adaptimmune Therapeutics Plc since year 2005. Table 2 shows the detailed insider transactions of Adaptimmune Therapeutics Plc since 2005. The reporting company's ticker symbol is ADAP. The reporting company's CIK number is 1621227.
The total value of stock buying since 2005 is $135,881,232.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Adaptimmune Therapeutics Plc (ADAP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-03 131,080,952 $100,089,998 0 $0 0 $0
2016-05 3,484,800 $35,791,234 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Adaptimmune Therapeutics Plc insiders (ADAP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-03-27 Florence Anthony A. Jr. (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Sonsini Peter W. (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Nea 14 Gp, Ltd (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Viswanathan Ravi (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Thompson Peter A. Buy 1,190,476 4.20 4,999,999
2017-03-27 Baskett Forest (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Sandell Scott D (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Kerins Patrick J (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Mott David M (Director) Buy 12,870,000 .70 9,009,000
2017-03-27 Barrett M James (10% Owner) Buy 12,870,000 .70 9,009,000
2017-03-27 Isaly Samuel D Buy 1,190,476 4.20 4,999,999
2017-03-27 Barris Peter J (10% Owner) Buy 12,870,000 .70 9,009,000
2016-05-24 Thompson Peter A. Buy 518,400 10.48 5,432,832
2016-05-24 Isaly Samuel D Buy 518,400 10.48 5,432,832
2016-05-23 Thompson Peter A. Buy 1,191,600 10.40 12,392,640
2016-05-23 Isaly Samuel D Buy 1,191,600 10.40 12,392,640
2016-05-20 Thompson Peter A. Buy 2,400 10.04 24,095
2016-05-20 Isaly Samuel D Buy 2,400 10.04 24,095
2016-05-19 Sigal Charles Elliott (Director) Buy 15,000 1.56 23,400
2016-05-18 Sigal Charles Elliott (Director) Buy 15,000 1.55 23,250
2016-05-17 Sigal Charles Elliott (Director) Buy 15,000 1.53 22,950
2016-05-16 Sigal Charles Elliott (Director) Buy 15,000 1.50 22,500

Insider trading activities including stock purchases, stock sales, and option exercises of ADAP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adaptimmune Therapeutics Plc (symbol ADAP, CIK number 1621227) see the Securities and Exchange Commission (SEC) website.